Argireline: a cosmetic peptide and its documentation

What it is, and what its name tells you

Argireline is a hexapeptide with an acetylated N-terminus and a C-terminal amide. Its systematic name in cosmetic ingredient nomenclature is acetyl hexapeptide-8, and that naming convention is itself informative: it comes from the INCI system used for cosmetic ingredients rather than from the research-chemical tradition that produced names like BPC-157 or GHRP-2.

The sequence is derived from a fragment of a protein involved in vesicle fusion, and it carries both terminal modifications — capped at one end, amidated at the other.

Two caps, two checks

This compound is modified at both ends, which means two of the checks described elsewhere in this library apply to the same molecule at once:

• The acetyl cap adds about 42 mass units. Material that never received it is a plausible impurity — the same situation as Thymosin alpha-1.
• The C-terminal amide is about one unit lighter than the free acid. Material left as the acid is separable chromatographically — the same situation as Ipamorelin and the GHRP family.

Both failures produce a legitimate peptide that is not this product. Together they are the reason the stated molecular formula matters more than a rounded mass here.

Where cosmetic-ingredient documentation differs

Materials supplied into the cosmetic trade are frequently documented to a different convention than research chemicals, and it is worth knowing what to expect:

1. Concentration rather than mass. Cosmetic ingredients are often supplied as dilute solutions and specified by percentage rather than as a lyophilized solid of a stated weight. A specification for a 5 per cent solution is not comparable to a certificate for a solid.
2. Specification sheets in place of lot certificates. A document describing what the material should be is not the same as a report describing the lot you received. See lot traceability.
3. Purity conventions differ. Cosmetic-grade specifications may be written against different acceptance criteria than an analytical certificate, and the two are not directly comparable numbers.

The question to settle before ordering is simply which kind of document is on offer: a lot-specific analytical report, or a general specification. The first describes your vial; the second describes the product line.

Storage of the lyophilized solid

Supplied as a freeze-dried solid, governed by temperature and moisture. With no cysteine, methionine or tryptophan in the sequence, neither oxidation nor light is a primary concern — this is an undemanding compound to store, and the acetyl and amide caps are stable covalent modifications rather than fragile ones.

Stability is a documented property rather than an assumed one: a laboratory establishes it by holding material under defined conditions and re-analysing at intervals. Where a retest date is stated, the question worth asking is what data supports it. See storing lyophilized research materials.

Scope of this documentation

This page concerns material identification and analytical documentation for laboratory research. It does not recommend personal, human, clinical, therapeutic or veterinary applications. Published research findings do not establish the properties of Arctic stock; use the applicable lot record and its stated methods and limitations.

Related documentation